BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16868038)

  • 1. Oestroprogestagens and severe acute pyelonephritis: a casual or causal association?
    Piccoli GB; Colla L; Mezza E; Burdese M; Cammarota T; Piccoli G
    Nephrol Dial Transplant; 2006 Aug; 21(8):2337. PubMed ID: 16868038
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current aspects of the oral hormonal contraception].
    Avramova V
    Akush Ginekol (Sofiia); 2008; 47 Suppl 2():49-59. PubMed ID: 19504710
    [No Abstract]   [Full Text] [Related]  

  • 3. Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment.
    Cogliano V; Grosse Y; Baan R; Straif K; Secretan B; El Ghissassi F;
    Lancet Oncol; 2005 Aug; 6(8):552-3. PubMed ID: 16094770
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancer.
    Shapiro S
    Lancet Oncol; 2005 Oct; 6(10):736; author reply 737. PubMed ID: 16198976
    [No Abstract]   [Full Text] [Related]  

  • 5. [Colpocytological patterns after prolonged treatment with combined estroprogestinic drugs].
    Vernotico V; Zanella B
    Minerva Ginecol; 1975 Jun; 27(6):448-56. PubMed ID: 1153121
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of hormone replacement therapy in the management of premature ovarian failure.
    Christin-Maitre S
    Nat Clin Pract Endocrinol Metab; 2008 Feb; 4(2):60-1. PubMed ID: 18030288
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in use of hormone replacement therapy after the report from the Women's Health Initiative: cross sectional survey of users.
    Lawton B; Rose S; McLeod D; Dowell A
    BMJ; 2003 Oct; 327(7419):845-6. PubMed ID: 14551101
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of hormonal therapy related thrombosis.
    Sandset PM
    Thromb Res; 2013 Jan; 131 Suppl 1():S4-7. PubMed ID: 23452740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reviews of hormone replacement therapy evidence support findings in recently halted trial.
    Levenson D
    Rep Med Guidel Outcomes Res; 2002 Sep; 13(17):7-9. PubMed ID: 12572547
    [No Abstract]   [Full Text] [Related]  

  • 10. Hormone replacement therapy and the risk of breast cancer.
    Cuzick J
    Eur J Cancer; 2008 Nov; 44(16):2344-9. PubMed ID: 18783940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmenopausal hormone therapy and breast cancer.
    Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HRT 2000: pause for thought.
    Harv Womens Health Watch; 2000 Apr; 7(8):1-3. PubMed ID: 10712769
    [No Abstract]   [Full Text] [Related]  

  • 13. [Secondary amenorrhea following ovulation inhibitors].
    Kunz J; Keller PJ
    Schweiz Med Wochenschr; 1974 Jun; 104(26):923-7. PubMed ID: 4422939
    [No Abstract]   [Full Text] [Related]  

  • 14. Hormonal contraception: noncontraceptive benefits and medical contraindications.
    Rager KM; Omar HA
    Adolesc Med Clin; 2005 Oct; 16(3):539-51. PubMed ID: 16183538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oral contraceptives: update].
    Fugère P
    Union Med Can; 1983 Feb; 112(2):109-12. PubMed ID: 6845551
    [No Abstract]   [Full Text] [Related]  

  • 16. [Indications for the therapeutic use of contraceptive steroids].
    Nocke W
    Med Welt; 1975 Aug; 6(35):1509-17. PubMed ID: 1100993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone therapy. An update on risks and benefits.
    Mayo Clin Womens Healthsource; 2009 Mar; Suppl():1-8. PubMed ID: 19405167
    [No Abstract]   [Full Text] [Related]  

  • 18. [Estrogen use in systemic lupus erythematosus].
    Ketari S; Cherif O; Boussema F; Kochbati S; Ben Dhaou B; Rokbani L
    Gynecol Obstet Fertil; 2005 Oct; 33(10):783-90. PubMed ID: 16139552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
    von Schoultz B
    Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143
    [No Abstract]   [Full Text] [Related]  

  • 20. Postmenopausal hormone replacement therapy and risk of acute pancreatitis: a population-based case-control study.
    Tetsche MS; Jacobsen J; Nørgaard M; Baron JA; Sørensen HT
    Am J Gastroenterol; 2007 Feb; 102(2):275-8. PubMed ID: 17311649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.